CN108478678A - A kind of pharmaceutical composition of Weight-reducing health - Google Patents

A kind of pharmaceutical composition of Weight-reducing health Download PDF

Info

Publication number
CN108478678A
CN108478678A CN201810491081.8A CN201810491081A CN108478678A CN 108478678 A CN108478678 A CN 108478678A CN 201810491081 A CN201810491081 A CN 201810491081A CN 108478678 A CN108478678 A CN 108478678A
Authority
CN
China
Prior art keywords
parts
pharmaceutical composition
weight
mixture
seed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810491081.8A
Other languages
Chinese (zh)
Inventor
路培育
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201810491081.8A priority Critical patent/CN108478678A/en
Publication of CN108478678A publication Critical patent/CN108478678A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/482—Cassia, e.g. golden shower tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind of pharmaceutical compositions of Weight-reducing health, pharmaceutical composition component includes 10 20 parts of corydalis tuber in parts by weight, 5 15 parts of green peel, 4 12 parts of Poria cocos, 8 18 parts of Caulis et Folium Brassicae capitatae, 10 20 parts of grape seed extract, 39 parts of microcrystalline cellulose, 4 10 parts of pomegranate seed, 5 12 parts of cassia seed, 3 10 parts of sesame slices, 6 16 parts of rhizoma typhonii, 8 12 parts of tea polyphenols, 14 parts of Cr-enriched yeast, preparation method of the present invention is simple, pharmaceutical composition obtained has reducing blood lipid, reduce cholesterol, it relaxes bowel, clearing heat and detoxicating effect, in addition, weight losing function effect is good, it is quick and without side-effects.

Description

A kind of pharmaceutical composition of Weight-reducing health
Technical field
The present invention relates to slimming medicine preparing technical field, specially a kind of pharmaceutical composition of Weight-reducing health.
Background technology
With the affluence of development people's life of social economy, obesity person is more and more, not only gives work and life Inconvenience is brought, it is especially fat to be easy to induce hypertension, diabetes, heart disease, coronary heart disease, fatty liver, hepatic sclerosis, cancer etc. A variety of difficult and complicated cases and the higher death rate, thus great stress is caused to obese people, at present by medical circles Or even the common concern of society.Currently, the elimination for transition obesity, physics gimmick and the lipid-loweringings such as doctor trained in Western medicine liposuction, combustion fat, operation Medicinal treatment, middle medical circles then advocate movement, diet and recommend low-heat, low fat, the diet structure of low sugar, these methods one are to subtract Fertilizer efficiency fruit is poor, and is easy rebound；Second is that many side effects are easy tod produce, to some extent with damage health for cost, so It is difficult to be received by obese people.Nearly period comes, and there are many technologies fat using Chinese herbal medicine elimination in middle medical circles, can be very good The generation of toxic side effect is avoided, it is more safe.But various prescriptions are taken a broad view of, using lipid-loweringing, the Chinese herb medicine of activating blood and clearing heat, with It eliminates exterior syndrome to be limited, defect one is that drug effect is slow, and length makes patient lose confidence and interrupts treatment；Second is that difficulty is basic, it is easy Rebound has getting fat to be easy the anxiety of weight-reducing hardly possible.
Invention content
The purpose of the present invention is to provide a kind of pharmaceutical compositions of Weight-reducing health, to solve to propose in above-mentioned background technology The problem of.
To achieve the above object, the present invention provides the following technical solutions：A kind of pharmaceutical composition of Weight-reducing health, medicine group Polymer component in parts by weight include 10-20 parts of corydalis tuber, 5-15 parts of green peel, 4-12 parts of Poria cocos, 8-18 parts of Caulis et Folium Brassicae capitatae, It is 10-20 parts of grape seed extract, 3-9 parts of microcrystalline cellulose, 4-10 parts of pomegranate seed, 5-12 parts of cassia seed, 3-10 parts of sesame slices, white attached 6-16 parts sub-, 8-12 parts of tea polyphenols, 1-4 parts of Cr-enriched yeast.
Preferably, the preferred composition proportion of pharmaceutical composition component includes 15 parts of corydalis tuber, 10 parts of green peel, 8 parts of Poria cocos, west It is 13 parts of orchid extract, 15 parts of grape seed extract, 6 parts of microcrystalline cellulose, 7 parts of pomegranate seed, 9 parts of cassia seed, 7 parts of sesame slices, white 11 parts of monkshood, 10 parts of tea polyphenols, 3 parts of Cr-enriched yeast.
Preferably, preparation method includes the following steps：
A, it is added in grinder and grinds after mixing corydalis tuber, green peel, Poria cocos, pomegranate seed, cassia seed, sesame slices, rhizoma typhonii, Milling time is 20min-40min, is sieved with 100 mesh sieve later, and mixture A is obtained；
B, Caulis et Folium Brassicae capitatae, grape seed extract, microcrystalline cellulose, Cr-enriched yeast are added in mixture A, after mixing It is put into heating tank and carries out heating mixing, heating temperature is 80 DEG C -100 DEG C, and time 10min-20min keeps the temperature 20min later Slow cooling obtains mixture B to room temperature afterwards；
C, by mixture B under vacuum conditions to 10h to get to pharmaceutical composition.
Compared with prior art, the beneficial effects of the invention are as follows：Preparation method of the present invention is simple；Wherein, add in the present invention The corydalis tuber added can speed up aliphatic acid from internal discharge；The Caulis et Folium Brassicae capitatae of addition has functions of lowering blood-fat and reducing weight；Addition Grape seed extract has eliminating dampness and diuresis, and strengthening the spleen and stomach, sharp key dries, lead it is turbid promote the production of body fluid, tonifying spleen-yin, born fluid effect；Addition Pomegranate seed has yin-nourishing of enriching blood, nourishing liver and kidney, life essence-filling, marrow-benefitting effect；The sesame slices of addition have effects that clearing heat and cooling blood；More than Pharmaceutical composition made from mixture has reducing blood lipid, reduces cholesterol, relaxes bowel, clearing heat and detoxicating effect, in addition, weight-reducing Functional effect is good, quick and without side-effects.
Specific implementation mode
The following is a clear and complete description of the technical scheme in the embodiments of the invention, it is clear that described embodiment Only a part of the embodiment of the present invention, instead of all the embodiments.Based on the embodiments of the present invention, the common skill in this field The every other embodiment that art personnel are obtained without making creative work belongs to the model that the present invention protects It encloses.
The present invention provides the following technical solutions：A kind of pharmaceutical composition of Weight-reducing health, pharmaceutical composition component is by weight Number includes 10-20 parts of corydalis tuber, 5-15 parts of green peel, 4-12 parts of Poria cocos, 8-18 parts of Caulis et Folium Brassicae capitatae, grape seed extract 10-20 parts, 3-9 parts of microcrystalline cellulose, 4-10 parts of pomegranate seed, 5-12 parts of cassia seed, 3-10 parts of sesame slices, 6-16 parts of rhizoma typhonii, tea 8-12 parts of polyphenol, 1-4 parts of Cr-enriched yeast.
Embodiment one：
Pharmaceutical composition component includes 10 parts of corydalis tuber, 5 parts of green peel, 4 parts of Poria cocos, Caulis et Folium Brassicae capitatae 8 in parts by weight Part, 10 parts of grape seed extract, 3 parts of microcrystalline cellulose, 4 parts of pomegranate seed, 5 parts of cassia seed, 3 parts of sesame slices, 6 parts of rhizoma typhonii, tea are more 8 parts of phenol, 1 part of Cr-enriched yeast.
The preparation method of the present embodiment includes the following steps：
A, it is added in grinder and grinds after mixing corydalis tuber, green peel, Poria cocos, pomegranate seed, cassia seed, sesame slices, rhizoma typhonii, Milling time is 20min, is sieved with 100 mesh sieve later, and mixture A is obtained；
B, Caulis et Folium Brassicae capitatae, grape seed extract, microcrystalline cellulose, Cr-enriched yeast are added in mixture A, after mixing Be put into heating tank and carry out heating mixing, heating temperature be 80 DEG C, time 10min, later keep the temperature 20min after slow cooling extremely Room temperature obtains mixture B；
C, by mixture B under vacuum conditions to 10h to get to pharmaceutical composition.
Embodiment two：
Pharmaceutical composition component includes 20 parts of corydalis tuber, 15 parts of green peel, 12 parts of Poria cocos, Caulis et Folium Brassicae capitatae in parts by weight 18 parts, 20 parts of grape seed extract, 9 parts of microcrystalline cellulose, 10 parts of pomegranate seed, 12 parts of cassia seed, 10 parts of sesame slices, rhizoma typhonii 16 Part, 12 parts of tea polyphenols, 4 parts of Cr-enriched yeast.
The preparation method of the present embodiment includes the following steps：
A, it is added in grinder and grinds after mixing corydalis tuber, green peel, Poria cocos, pomegranate seed, cassia seed, sesame slices, rhizoma typhonii, Milling time is 40min, is sieved with 100 mesh sieve later, and mixture A is obtained；
B, Caulis et Folium Brassicae capitatae, grape seed extract, microcrystalline cellulose, Cr-enriched yeast are added in mixture A, after mixing It is put into heating tank and carries out heating mixing, heating temperature is 100 DEG C, time 20min, keeps the temperature slow cooling after 20min later To room temperature, mixture B is obtained；
C, by mixture B under vacuum conditions to 10h to get to pharmaceutical composition.
Embodiment three：
Pharmaceutical composition component includes 12 parts of corydalis tuber, 7 parts of green peel, 5 parts of Poria cocos, Caulis et Folium Brassicae capitatae 10 in parts by weight Part, 12 parts of grape seed extract, 4 parts of microcrystalline cellulose, 5 parts of pomegranate seed, 6 parts of cassia seed, 4 parts of sesame slices, 7 parts of rhizoma typhonii, tea are more 9 parts of phenol, 2 parts of Cr-enriched yeast.
The preparation method of the present embodiment includes the following steps：
A, it is added in grinder and grinds after mixing corydalis tuber, green peel, Poria cocos, pomegranate seed, cassia seed, sesame slices, rhizoma typhonii, Milling time is 25min, is sieved with 100 mesh sieve later, and mixture A is obtained；
B, Caulis et Folium Brassicae capitatae, grape seed extract, microcrystalline cellulose, Cr-enriched yeast are added in mixture A, after mixing Be put into heating tank and carry out heating mixing, heating temperature be 85 DEG C, time 12min, later keep the temperature 20min after slow cooling extremely Room temperature obtains mixture B；
C, by mixture B under vacuum conditions to 10h to get to pharmaceutical composition.
Example IV：
Pharmaceutical composition component includes 18 parts of corydalis tuber, 13 parts of green peel, 10 parts of Poria cocos, Caulis et Folium Brassicae capitatae in parts by weight 16 parts, 18 parts of grape seed extract, 8 parts of microcrystalline cellulose, 9 parts of pomegranate seed, 10 parts of cassia seed, 9 parts of sesame slices, 14 parts of rhizoma typhonii, 10 parts of tea polyphenols, 3 parts of Cr-enriched yeast.
The preparation method of the present embodiment includes the following steps：
A, it is added in grinder and grinds after mixing corydalis tuber, green peel, Poria cocos, pomegranate seed, cassia seed, sesame slices, rhizoma typhonii, Milling time is 35min, is sieved with 100 mesh sieve later, and mixture A is obtained；
B, Caulis et Folium Brassicae capitatae, grape seed extract, microcrystalline cellulose, Cr-enriched yeast are added in mixture A, after mixing Be put into heating tank and carry out heating mixing, heating temperature be 95 DEG C, time 18min, later keep the temperature 20min after slow cooling extremely Room temperature obtains mixture B；
C, by mixture B under vacuum conditions to 10h to get to pharmaceutical composition.
Embodiment five：
Pharmaceutical composition component includes 14 parts of corydalis tuber, 12 parts of green peel, 6 parts of Poria cocos, Caulis et Folium Brassicae capitatae in parts by weight 15 parts, 16 parts of grape seed extract, 4 parts of microcrystalline cellulose, 5 parts of pomegranate seed, 9 parts of cassia seed, 4 parts of sesame slices, 14 parts of rhizoma typhonii, tea 9 parts of polyphenol, 2 parts of Cr-enriched yeast.
The preparation method of the present embodiment includes the following steps：
A, it is added in grinder and grinds after mixing corydalis tuber, green peel, Poria cocos, pomegranate seed, cassia seed, sesame slices, rhizoma typhonii, Milling time is 28min, is sieved with 100 mesh sieve later, and mixture A is obtained；
B, Caulis et Folium Brassicae capitatae, grape seed extract, microcrystalline cellulose, Cr-enriched yeast are added in mixture A, after mixing Be put into heating tank and carry out heating mixing, heating temperature be 88 DEG C, time 14min, later keep the temperature 20min after slow cooling extremely Room temperature obtains mixture B；
C, by mixture B under vacuum conditions to 10h to get to pharmaceutical composition.
Embodiment six：
Pharmaceutical composition component includes 15 parts of corydalis tuber, 10 parts of green peel, 8 parts of Poria cocos, Caulis et Folium Brassicae capitatae in parts by weight 13 parts, 15 parts of grape seed extract, 6 parts of microcrystalline cellulose, 7 parts of pomegranate seed, 9 parts of cassia seed, 7 parts of sesame slices, 11 parts of rhizoma typhonii, tea 10 parts of polyphenol, 3 parts of Cr-enriched yeast.
The preparation method of the present embodiment includes the following steps：
A, it is added in grinder and grinds after mixing corydalis tuber, green peel, Poria cocos, pomegranate seed, cassia seed, sesame slices, rhizoma typhonii, Milling time is 30min, is sieved with 100 mesh sieve later, and mixture A is obtained；
B, Caulis et Folium Brassicae capitatae, grape seed extract, microcrystalline cellulose, Cr-enriched yeast are added in mixture A, after mixing Be put into heating tank and carry out heating mixing, heating temperature be 90 DEG C, time 15min, later keep the temperature 20min after slow cooling extremely Room temperature obtains mixture B；
C, by mixture B under vacuum conditions to 10h to get to pharmaceutical composition.
Model case：
Chen, man, 56 years old, Nanyang civil servant, 1.70 meters of height, 88 kilograms of weight, constitutional index (BMI) was 30.8, Belong to severe simple obesity, takes the Weight-reducing health composition of medicine of the present invention, 3 times a day, each taking 20 grams, weight subtracts after taking 30 days To 75 kilograms, weight reduces to 65 kilograms after taking 90 days, and with a slim and graceful figure, and blood pressure is normal.
Vehicle, female, 32 years old, Dengzhou City company personnel, 1.68 meters of height, 77 kilograms of weight, constitutional index (BMI) was 27.5, belong to fat, the Weight-reducing health composition of medicine for taking the present invention each taking 10 grams, takes weight after 30 days 3 times a day 63 kilograms are reduced to, weight reduces to 55 kilograms after taking 80 days, and with a slim and graceful figure, activities are normal, and follow-up is again without rebound.
Preparation method of the present invention is simple；Wherein, the corydalis tuber added in the present invention can speed up aliphatic acid from internal discharge； The Caulis et Folium Brassicae capitatae of addition has functions of lowering blood-fat and reducing weight；The grape seed extract of addition has eliminating dampness and diuresis, strengthening the spleen and stomach, profit Key dries, lead it is turbid promote the production of body fluid, tonifying spleen-yin, born fluid effect；The pomegranate seed of addition has yin-nourishing of enriching blood, nourishing liver and kidney, life essence-filling, marrow-benefitting Effect；The sesame slices of addition have effects that clearing heat and cooling blood；There is reducing blood lipid using pharmaceutical composition made from the above mixture, reduce Cholesterol relaxes bowel, clearing heat and detoxicating effect, in addition, weight losing function effect is good, it is quick and without side-effects.
It although an embodiment of the present invention has been shown and described, for the ordinary skill in the art, can be with Understanding without departing from the principles and spirit of the present invention can carry out these embodiments a variety of variations, modification, replace And modification, the scope of the present invention is defined by the appended.

Claims (3)

1. a kind of pharmaceutical composition of Weight-reducing health, it is characterised in that：Pharmaceutical composition component includes corydalis tuber in parts by weight 10-20 parts, 5-15 parts of green peel, 4-12 parts of Poria cocos, 8-18 parts of Caulis et Folium Brassicae capitatae, 10-20 parts of grape seed extract, microcrystalline cellulose 3-9 parts plain, 4-10 parts of pomegranate seed, 5-12 parts of cassia seed, 3-10 parts of sesame slices, 6-16 parts of rhizoma typhonii, 8-12 parts of tea polyphenols, chromium-rich ferment It is 1-4 parts female.
2. a kind of pharmaceutical composition of Weight-reducing health according to claim 1, it is characterised in that：Pharmaceutical composition component is excellent The composition proportion of choosing includes 15 parts of corydalis tuber, 10 parts of green peel, 8 parts of Poria cocos, 13 parts of Caulis et Folium Brassicae capitatae, grape seed extract 15 Part, 6 parts of microcrystalline cellulose, 7 parts of pomegranate seed, 9 parts of cassia seed, 7 parts of sesame slices, 11 parts of rhizoma typhonii, 10 parts of tea polyphenols, Cr-enriched yeast 3 Part.
3. realizing a kind of preparation method of the pharmaceutical composition of Weight-reducing health described in claim 1, it is characterised in that：It is prepared Method includes the following steps：
A, it is added in grinder and grinds after mixing corydalis tuber, green peel, Poria cocos, pomegranate seed, cassia seed, sesame slices, rhizoma typhonii, grind Time is 20min-40min, is sieved with 100 mesh sieve later, and mixture A is obtained；
B, Caulis et Folium Brassicae capitatae, grape seed extract, microcrystalline cellulose, Cr-enriched yeast are added in mixture A, is put into after mixing Heating mixing is carried out in heating tank, heating temperature is 80 DEG C -100 DEG C, time 10min-20min, is delayed after keeping the temperature 20min later Slowly it is cooled to room temperature, obtains mixture B；
C, by mixture B under vacuum conditions to 10h to get to pharmaceutical composition.
CN201810491081.8A 2018-05-21 2018-05-21 A kind of pharmaceutical composition of Weight-reducing health Pending CN108478678A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810491081.8A CN108478678A (en) 2018-05-21 2018-05-21 A kind of pharmaceutical composition of Weight-reducing health

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810491081.8A CN108478678A (en) 2018-05-21 2018-05-21 A kind of pharmaceutical composition of Weight-reducing health

Publications (1)

Publication Number Publication Date
CN108478678A true CN108478678A (en) 2018-09-04

Family

ID=63353481

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810491081.8A Pending CN108478678A (en) 2018-05-21 2018-05-21 A kind of pharmaceutical composition of Weight-reducing health

Country Status (1)

Country Link
CN (1) CN108478678A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102526360A (en) * 2011-10-17 2012-07-04 宁波海逸生物科技有限公司 Formula of health-care medicine with weight loss function
KR20150057119A (en) * 2013-11-18 2015-05-28 대한민국(농촌진흥청장) Pharmaceutical composition comprising ginseng maturation fruit extract for the prevention and treatment of obesity
CN105031042A (en) * 2015-06-26 2015-11-11 天津铸源健康科技集团有限公司 Medicinal composition having weight-loss function and application of medicinal composition
CN105147983A (en) * 2013-10-22 2015-12-16 南阳市食用菌技术交流中心（普通合伙） Weight-losing health medicine

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102526360A (en) * 2011-10-17 2012-07-04 宁波海逸生物科技有限公司 Formula of health-care medicine with weight loss function
CN105147983A (en) * 2013-10-22 2015-12-16 南阳市食用菌技术交流中心（普通合伙） Weight-losing health medicine
KR20150057119A (en) * 2013-11-18 2015-05-28 대한민국(농촌진흥청장) Pharmaceutical composition comprising ginseng maturation fruit extract for the prevention and treatment of obesity
CN105031042A (en) * 2015-06-26 2015-11-11 天津铸源健康科技集团有限公司 Medicinal composition having weight-loss function and application of medicinal composition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
俞学峰: "《酵母营养的奥秘》", 30 April 2017, 电子科技大学出版社 *
王慧敏: "《植物油图鉴》", 30 April 2016, 山西科学技术出版社 *

Similar Documents

Publication Publication Date Title
CN102428832B (en) Fungal pharmaceutical mycoplasm with blood sugar lowering efficacy and preparation method thereof
CN103099105A (en) Porridge with diabetes mellitus treating effect and preparation method of porridge
CN1824001A (en) Medicine and food duel purpose Chinese medicinal product for preventing and treating pharyngolaryngitis and its manufacturing method
CN110846185A (en) Rhizoma polygonati wine and preparation method thereof
CN105795263A (en) Health beverage for enhancing immunity and regulating human body functions and preparation method thereof
CN102327512B (en) Traditional Chinese medicine formula for treating prostatitis
CN106635729A (en) Preparation method of hawthorn vinegar
CN108478678A (en) A kind of pharmaceutical composition of Weight-reducing health
CN103343078B (en) Production process of golden stichopus japonicus health-care yellow wine
CN103341092A (en) Preparation method of powder for treating atrophic vaginitis
CN105919111A (en) Fruit enzyme and preparation method thereof
CN105267662A (en) Okra and fenugreek health tea and preparation method thereof
CN102210363B (en) Beverage capable of reducing blood pressure, blood fat and blood viscosity and preparation method
CN111150777A (en) Traditional Chinese medicine composition with function of treating diabetes and preparation method thereof
CN103285113B (en) Pharmaceutical composition for preventing and/or treating diabetes mellitus
CN107496860A (en) A kind of capsule medicine for treating diabetes and preparation method thereof
CN102716342A (en) Medicine for treating diabetes
CN106266026A (en) A kind of curcumin composition of Antialcoholic liver-protecting
CN102145088B (en) Pharmaceutical composition for treating bronchial asthma and preparation method of pharmaceutical composition
CN110464814A (en) A kind of external application Chinese medicine and preparation method thereof for treating taste intestinal disease
CN102000244B (en) Traditional Chinese medicine preparation for treating diabetes mellitus
CN104547259B (en) A kind of Traditional Chinese medicine for decreasing blood sugar acetum
CN102380017A (en) Medicament for treating diabetes and preparation method of medicament
CN103330867A (en) Preparation method of powder for treating senile vaginitis
CN106492078A (en) A kind of treat Chinese medicine composition of lung cancer and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180904

WD01 Invention patent application deemed withdrawn after publication